KIM LEARY: FULL-TIME ONCOLOGY NURSE COPES WITH LOW GRADE GLIOMAAfter Kim Leary returned to nursing following treatment from a grade II astrocytoma, there was a time when she couldn’t work due to the demands of the role. Learn how Leary overcame the obstacles. |
ABTA ENGAGES WITH 100 INTERNATIONAL BRAIN TUMOR EXPERTSABTA joins brain tumor experts at a groundbreaking initiative designed to foster collaboration to expedite development of new treatments. |
AMY’S WALK—HEALING STEP BY STEPAshlie Thornbury and her family celebrate the life and spirit of her aunt, Amy, who was diagnosed with a brain tumor at the age of 37. |
APRIL 6, 2019 |
APRIL 13, 2019 |
APRIL 14, 2019 |
About Meet Hope Head On
Because of the generous support from people like you, the ABTA has given over $35 million for brain tumor research. The ABTA’s campaign, “Meet Hope Head On,” created for our 50th anniversary, is focused on raising $50 million, in part to fund critical brain tumor research. This campaign is vital for continuing the kind of work that led to the recent FDA approval of vorasidenib, a breakthrough treatment for low-grade glioma.